Research

The CCI awarded 18 seed grants to nine Virginia public universities for a total of $1.61M to address how artificial intelligence can make networks more secure, create new vulnerabilities, and more.

Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.

One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.

The Commonwealth BioAccelerator officially opened its doors, transforming 6,500 square feet of cutting-edge lab space into a launchpad for Virginia's most promising biotech ventures.

CvilleBioHub, a regional, industry-led organization, received a $4.3 million GO Virginia award and is partnering with UVA to establish the region's first laboratory accelerator at North Fork.

As part of the new institute, UVA's Biocomplexity Institute (BI) is contributing innovative AI research and solutions that will bolster efforts to detect illicit financial activity and address vulnerabilities within global supply chains.

A statewide biopharma boom is fueled by talent emerging from Virginia's universities, which provide a steady pipeline of specialized labor.

The Office of the Director of National Intelligence was the catalyst for the institute, with the goal of using next-gen technology to identify potential security threats and protect Americans.

The Virginia Catalyst Fund encourages collaboration with over 30 industry partners in collaboration with Virginia universities, including UVA.

UVA is a member of the Virginia Alliance for Semiconductor Technology (VAST), a coalition established to elevate Virginia as a leader on the forefront of the burgeoning semiconductor industry.

The UVA Manning Institute of Biotechnology positions UVA at the very forefront of cutting-edge medicine, such as cellular and gene therapies that revolutionize how diseases are treated and cured.

Explore 2022's first quarter edition of the Virginia Economic Review featuring a story on UVA and its support for the life sciences industry in Charlottesville (p. 32).